Mark Connors Selected Research

HIV Antigens

3/2007	Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load.
10/2003	Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Connors Research Topics

Disease

32	Infections 01/2022 - 03/2004
10	HIV Infections (HIV Infection) 01/2018 - 01/2002
8	Viremia 01/2017 - 10/2003
6	Persistent Infection 12/2016 - 11/2005
5	Human Influenza (Influenza) 01/2021 - 03/2007
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 06/2007
4	Disease Progression 06/2006 - 03/2004
2	Virus Diseases (Viral Diseases) 11/2020 - 05/2013
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Neoplasms (Cancer) 10/2017
1	Immune Reconstitution Inflammatory Syndrome 12/2006
1	Hepatitis C 09/2006
1	Liver Diseases (Liver Disease) 09/2006
1	Melanoma (Melanoma, Malignant) 10/2004

Drug/Important Bio-Agent (IBA)

11	AntibodiesIBA 01/2022 - 03/2004
11	VaccinesIBA 01/2021 - 04/2004
8	Broadly Neutralizing AntibodiesIBA 12/2019 - 03/2015
5	AntigensIBA 01/2021 - 04/2003
4	EpitopesIBA 01/2022 - 04/2009
4	Neutralizing AntibodiesIBA 01/2018 - 01/2009
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 11/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 05/2012
3	AIDS VaccinesIBA 02/2011 - 06/2006
3	CytokinesIBA 07/2008 - 12/2006
3	Interleukin-2 (IL2)IBA 03/2007 - 01/2002
2	Granzymes (Granzyme)IBA 11/2020 - 02/2013
2	Glycoproteins (Glycoprotein)IBA 01/2018 - 07/2014
2	Antiviral Agents (Antivirals)IBA 01/2017 - 12/2015
2	Immunoglobulins (Immunoglobulin)IBA 01/2014 - 04/2009
2	Interferon Type IIBA 04/2008 - 12/2006
2	HLA-B Antigens (HLA-B)IBA 06/2007 - 06/2003
2	HIV AntigensIBA 03/2007 - 10/2003
1	Monoclonal AntibodiesIBA 01/2022
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2021
1	PerforinIBA 11/2020
1	avian influenza A virus hemagglutininIBA 01/2019
1	vedolizumabIBA 01/2018
1	Hemagglutinins (Hemagglutinin)IBA 01/2018
1	Bispecific AntibodiesIBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Interleukin-12 (IL 12)IBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 04/2015
1	Pharmaceutical PreparationsIBA 04/2015
1	CCR5 Receptors (CCR5 Receptor)IBA 01/2015
1	Cell Surface ReceptorsIBA 07/2014
1	HLA-B57 antigenIBA 06/2011
1	LigandsIBA 06/2011
1	AutoantigensIBA 09/2010
1	Histocompatibility Antigens Class IIBA 07/2010
1	GP 140IBA 04/2009
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2009
1	Ribavirin (Virazole)FDA LinkGeneric 04/2008
1	Interferon-alpha (Interferon Alfa)IBA 04/2008
1	Interferon-alpha2bIBA 04/2008
1	RNA (Ribonucleic Acid)IBA 06/2007
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 03/2007
1	Interferon-gamma (Interferon, gamma)IBA 03/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007
1	LipopolysaccharidesIBA 12/2006
1	antineoplaston A10 (A 10)IBA 09/2006
1	Viral AntigensIBA 11/2005
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2004

Therapy/Procedure

6	Therapeutics 11/2016 - 12/2006
3	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 01/2002
1	Aftercare (After-Treatment) 11/2015
1	Art Therapy 11/2015